PharmaCyte Biotech, Inc. - 8-K Filing
PharmaCyte Biotech implements 1-for-19 reverse stock split to regain Nasdaq minimum bid price compliance. (Items: 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 8.01 Other Events, 9.01 Financial Statements and Exhibits)